Andrea Murino, a partner and co-chair of Goodwin’s Antitrust & Competition Law Practice, examines the latest on the Aetna Inc., Humana Inc. $33 billion purchase and why the U.S. government’s legal battle to try to reinstate the deal may fail.
The full Reuters article here.